Abstract
Antisense oligonucleotides (ASONs) and siRNAs have been applied extensively for the regulation of cellular and viral gene expression, and RNAi is currently one of the most promising new approaches for anti-tumor and anti-viral therapy. In order to improve bioactivity properties and physicochemical properties of siRNA, we synthesized a novel class of ASONs II–VII incorporated with amino-isonucleoside (isoA 1 and isoA 2 ) for investigation on basic physicochemical properties. Then we designed amino-isonucleoside (isoA 1 , isoA 2 and isoT 1 ) incorporated siRNA 2–7. Some meaningful results have been obtained from the physicochemical property experiments in ASONs. In RNAi potency experiments, we investigated RNAi potency of each strand of the siRNA. These amino-isonucleosides incorporated siRNAs showed promising bioactivity properties and had position specificity. Reduced off target effect from sense strand loading in siRNA application was observed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Kathleen FP, Antonina R, Leanne SS, Esther HC. Antisense therapeutics: From theory to clinical practice. Pharmac Therap, 2003, 99: 55–77
Kim DH, Rossi JJ. Overview of gene silencing by RNA interference. Curr Protoc Nucleic Acid Chem, 2009. Chapter 16. Unit 16.1
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001, 411(6836): 494–498
Chiang MY, Chan H, Zounes MA, Freier SM, Lima WF, Bennett CF. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J Biol Chem, 1991, 266: 18162–18171
Crooke ST. Oligonucleotide therapeutics. In: Burger's Medicinal Chemistry and Drug Discovery. Vol. 1: Principles and Practice. Wolff ME, Ed. John WS, Inc., New York, 1995. 863–900
Crooke ST. Oligonucleotide therapy. Curr Opin Biotechnol, 1992, 3: 656–661
Pushparaj PN, Aarthi JJ, Manikandan J, Kumar SD. siRNA, miRNA, and shRNA: In vivo applications. J Dent Res, 2008, 87(11): 992–1003
Whitehead KA, Langer R, Anderson DG. Knocking down barriers: Advances in siRNA delivery. Nat Rev Drug Discov, 2009, 8(2): 129–138
Wullner U, Neef I, Tur MK, Barth S. Targeted delivery of short interfering RNAs-strategies for in vivo delivery. Rec Patents Anti Can Drug Disc, 2009, 4(1): 1–8
Yang ZJ, Yu HW, Min JM, Ma LT, Zhang LH. Stereoselective synthesis of 4-deoxy-4-nucleobase-2,5-anhydro-L-mannitol derivatives. Tetrahedron Asymm, 1997, 8: 2739–2747
Wang JF, Yang XD, Zhang LR., Yang ZJ, Zhang LH. Synthesis and biological activities of 5′-ethylenic and acetylenic modified L-nucleosides and isonucleosides. Tetrahedron, 2004, 60: 8535–8546
Yu HW, Zhang LR, Zhou JC, Ma LT, Zhang LH. Studies on the synthesis and biological activities of 4′-(R)-hydroxy-5′-(S)-hydroxymethyl-tetrahydrofuranyl purines and pyrimidines. Bioorg Med Chem, 1996, 4: 609–614
Jiang CW, Li BC, Guan Z, Yang ZJ, Zhang LR, Zhang LH. Synthesis and recognition of novel isonucleoside triphosphates by DNA polymerases. Bioorg Med Chem, 2007, 15: 3019–3025
Lei Z, Min JM, Zhang LH. Synthesis of 3-deoxy-3-nucleobase-2,5-anhydro-D-mannitol: A novel class of hydroxymethyl-branched isonucleosides. Tetrahedron Asymm, 2000, 11: 2899–2906
Wang ZL, Shi JF, Jin HW, Zhang LR, Lu JF, Zhang LH. Properties of isonucleotide-incorporated oligodeoxynucleotides and inhibition of the expression of spike protein of SARS-CoV. Bioconj Chem, 2005, 16: 1081–1087
Bernard C, Florence C, Dieter H, François N, Romain MW, Karl-Heinz A, Pierre M, Heinz EM. Dual recognition of double-stranded DNA by 2'-aminoethoxy-modified oligonucleotides. Angew Chem Int Ed, 1998, 37: 1288–1291
Massey PA, Sigurdsson TS. Chemical syntheses of inhibitory substrates of the RNA-RNA ligation reaction catalyzed by the hairpin ribozyme. Nucleic Acids Res, 2004, 32: 2017–2022
Li ZS, Qiao RP, Du Q, Yang ZJ, Zhang LR, Zhang PZ, Liang ZC, Zhang LH. Studies on aminoisonucleoside modified siRNAs: stability and silencing activity. Bioconjug Chem, 2007, 18(4): 1017–1024
Du Q, Thonberg H, Zhang HY, Wahlestedt C, Liang ZC. Validating siRNA using a reporter made from synthetic DNA oligonucleotides. Biochem Biophys Res Commun, 2004, 325(1): 243–249
Matranga C, Tomari Y, Shin C, Barte DP, Zamore PD. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell, 2005, 123(4): 607–620
Kurreck J. RNA Interference: From basic research to therapeutic applications. Angew Chem Int Ed, 2009, 48(8): 1378–1398
Wei JX, Yang J, Sun JF, Jia LT, Zhang Y, Zhang HZ, Li X, Meng YL, Yao LB, Yang AG. Both strands of siRNA have potential to guide posttranscriptional gene silencing in mammalian cells. PLoS One, 2009, 4(4): e5382
Li F, Pallan PS, Maier MA, Rajeev KG, Mathieu SL, Kreutz C, Fan YP, Sanghvi J, Ronald M, Rozners E, Manoharan M, Egli M. Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme. Nucleic Acids Res, 2007, 35(19): 6424–6438
Clark PR, Pober JS, Kluger MS. Knockdown of TNFR1 by the sense strand of an ICAM-1 siRNA: Dissection of an off-target effect. Nucleic Acids Res, 2008. 36(4): 1081–1097
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work
Rights and permissions
About this article
Cite this article
Wang, F., Chen, Y., Huang, Y. et al. Synthesis, physicochemical and biological properties of oligonucleotides incorporated with amino-isonucleosides. Sci. China Chem. 55, 70–79 (2012). https://doi.org/10.1007/s11426-011-4465-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11426-011-4465-x